The Director, RWE, CMH role at Eli Lilly is responsible for developing and executing the Real-World Evidence strategy within Medical Affairs. This involves designing and overseeing observational studies, registries, and other real-world data analyses to inform clinical practice, regulatory decisions, and healthcare policy. The role requires collaboration with various internal and external stakeholders, including HEOR, Market Access, Regulatory, and KOLs, to generate and disseminate high-quality evidence across the product lifecycle.